This page shows you the latest news items in this category. This is page number 9.
Total 456 results found since Jan 2013.
Column: A stem cell clinic under fire by the FDA and ex-patients files for bankruptcy
A La Jolla clinic pitching $15,000 stem cell treatments files for bankruptcy, facing a lawsuit from former patients.
Source: Los Angeles Times - Science - September 12, 2019 Category: Science Authors: Michael Hiltzik Source Type: news
Ocean Heat Wave Off U.S. West Coast Could Badly Disrupt Marine Life, Scientists Say
(SEATTLE) — Federal scientists said Thursday they are monitoring a new ocean heat wave off the U.S. West Coast, a development that could badly disrupt marine life including salmon, whales and sea lions.
The expanse of unusually warm water stretches from Alaska to California, researchers with the National Oceanic and Atmospheric Administration said Thursday. It resembles a similar heat wave about five years ago that was blamed for poorer survival rates for young salmon, more humpback whales becoming entangled in fishing gear as they hunted closer to shore, and an algae bloom that shut down crabbing and clamming.
R...
Source: TIME: Science - September 5, 2019 Category: Science Authors: GENE JOHNSON / AP Tags: Uncategorized climate onetime Source Type: news
Clinical Trial Offering Personalized Immunotherapy for Mesothelioma
Patients with mesothelioma are now eligible for a multicancer clinical trial studying the effectiveness of personalized immunotherapy at the University of California, San Diego Medical Center.
The phase I clinical trial involves a combination of Keytruda (pembrolizumab), a proven immunotherapy drug, and an individualized vaccine based upon the genetic mutations found in each patient’s cancer.
“This is the future of cancer treatment,” Dr. Ezra Cohen, principal investigator and director of the San Diego Center for Precision Immunotherapy, told The Mesothelioma Center at Asbestos.com. “Now, we still have a lot to lear...
Source: Asbestos and Mesothelioma News - August 14, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news
Synthorx founder mysteriously leaves Scripps Research
A lead scientist at La Jolla ’s Scripps Research has left the biomedical institute
Source: PharmaManufacturing.com - August 9, 2019 Category: Pharmaceuticals Source Type: news
Study suggests arthroscopy more effective than MRI for chondral defects of the knee
(American Orthopaedic Society for Sports Medicine) Using arthroscopy to stage a lesion in the chondral area of the knee is more accurate than magnetic resonance imaging, according to researchers from the Rothman Institute, La Jolla, Calif. The findings were presented today at the American Orthopedic Society of Sports Medicine Annual Meeting.
Source: EurekAlert! - Medicine and Health - July 11, 2019 Category: International Medicine & Public Health Source Type: news
Dr. Teruko Ishizaka, Who Advanced Allergy Treatment, Dies at 92
She and her husband identified an antibody that triggers wheezing and rashes. Monitoring it can help prevent and remedy allergic reactions.
Source: NYT Health - June 14, 2019 Category: Consumer Health News Authors: Sam Roberts Tags: Allergies Ishizaka, Teruko (1926-2019) Deaths (Obituaries) Asthma Hay Fever Ishizaka, Kimishige (1925-2018) Tokyo (Japan) La Jolla (Calif) Doctors Source Type: news
De-TOXing exhausted T cells may bolster CAR T immunotherapy against solid tumors
(La Jolla Institute for Immunology) A decade ago researchers announced development of a cancer immunotherapy called CAR (for chimeric antigen receptor)-T, in which a patient is re-infused with their own genetically modified T cells equipped to mount a potent anti-tumor attack. Since then CAR T approaches (one of several strategies collectively known as 'adoptive T cell transfer') have made headlines as a novel cellular immunotherapy tool, most successfully against so-called 'liquid cancers' like leukemias and lymphomas.
Source: EurekAlert! - Cancer - May 27, 2019 Category: Cancer & Oncology Source Type: news
TET proteins regulate factors essential for normal antibody production
(La Jolla Institute for Immunology) A report by researchers at la Jolla Institute for Immunology found that genetic deletion, or mutation, of TET2 and TET3 in mouse B cells damps down the generation of functional IgG antibodies, decreasing the effectiveness of immune responses.
Source: EurekAlert! - Biology - April 26, 2019 Category: Biology Source Type: news
Can You Help ASCs Access the Latest Medtech Advances?
Ambulatory surgery centers (ASCs) are helping healthcare payers reduce costs and improve patient outcomes, Scott Leggett, CEO of Surgery One LLC, an ASC management company that works with outpatient surgical centers, told MD+DI. Outpatient surgical centers are quick to adopt new medical device technologies, he said, but they do have some tech needs that medical device manufacturers could help address.
ASCs are poised for “huge†growth, Leggett predicted. “Any procedures now being done in hospitals for qualified outpatient candidates are being encouraged to be performed ...
Source: MDDI - April 20, 2019 Category: Medical Devices Authors: Daphne Allen Tags: Business Source Type: news
This scientist thinks she has the key to curb climate change: super plants
Dr Joanne Chory hopes that genetic modifications to enhance plants ’ natural carbon-fixing traits could play a key role – but knows that time is short, for her and the planetIf this were a film about humanity ’s last hope before climate change wiped us out, Hollywood would be accused of flagrant typecasting. That’s becauseDr Joanne Chory is too perfect for the role to be believable.The esteemed scientist – who has long banged the climate drum and now leads a project that could lower the Earth’s temperature – is perhaps the world’s leading botanist and is on the cusp of something so big that it could truly c...
Source: Guardian Unlimited Science - April 16, 2019 Category: Science Authors: Adam Popescu in La Jolla, California Tags: Plants Climate change Environment Science Source Type: news
Scientists devise strategies to counteract T cell exhaustion in CAR T cancer therapies
(La Jolla Institute for Immunology) CAR T-cell therapies have saved lives in patients with blood cancers, but there has been a downside: T cells that enter solid tumors can stop working due to a phenomenon called T cell exhaustion.Now scientists at the La Jolla Institute of Immunology (LJI) have found a way of counteracting T cell exhaustion and making CAR T cell therapies more effective.
Source: EurekAlert! - Cancer - February 27, 2019 Category: Cancer & Oncology Source Type: news
Smaller Germinal Centers Identified in Recurrent Tonsillitis
MONDAY, Feb. 11, 2019 -- Children with recurrent tonsillitis (RT) have smaller germinal centers, according to a study published in the Feb. 6 issue of Science Translational Medicine.
Jennifer M. Dan, M.D., Ph.D., from La Jolla Institute for...
Source: Drugs.com - Pharma News - February 11, 2019 Category: Pharmaceuticals Source Type: news
Why your kid's strep throat keeps coming back
(La Jolla Institute for Immunology) Each year, some 600 million people around the world come down with strep throat. Yet, it was unclear why some kids are prone to repeated bouts of strep throat while others appear to be more or less immune. The latest study by researchers at La Jolla Institute for Immunology (LJI) provides the first clues why some children are more susceptible than others to contracting recurrent strep throat.
Source: EurekAlert! - Infectious and Emerging Diseases - February 6, 2019 Category: Infectious Diseases Source Type: news
Genome structure of malaria parasites linked to virulence
(University of California - Riverside) An international research team led by scientists at the University of California, Riverside, and the La Jolla Institute for Immunology has found that malaria parasite genomes are shaped by parasite-specific gene families, and that this genome organization strongly correlates with the parasite's virulence. The findings highlight the importance of spatial genome organization in gene regulation and the control of virulence in malaria parasites.
Source: EurekAlert! - Infectious and Emerging Diseases - February 4, 2019 Category: Infectious Diseases Source Type: news
Zika vaccines should induce responses by CD4+ T cells
(PLOS) Immune cells called CD4+ T cells could be important mediators of protection against the Zika virus, according to a study published Jan. 24 in the open-access journal PLOS Pathogens by Sujan Shresta of the La Jolla Institute for Allergy and Immunology, and colleagues. The findings support vaccine strategies that induce a protective CD4+ T cell response to the Zika virus.
Source: EurekAlert! - Infectious and Emerging Diseases - January 24, 2019 Category: Infectious Diseases Source Type: news
